(fra kommisjonsforordningen)

(1) Serine protease, endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase andendo-1,4- beta-glucanase, endo-1,3(4)-beta-glucanase, endo–1,4-beta-xylanase, 6-phytase, alphaamylase, protease, 6-phytase and muramidase were authorised as feed additives (‘feed additives concerned’) for different animal species by Commission Implementing Regulations (EU) 2021/1426, (EU) 2024/221, (EU) 2023/1333, (EU) 2024/1058, (EU) 2023/1342, (EU) 2024/778, (EU) 2024/2177, (EU) 2019/805, (EU) 2020/163, (EU) 2021/1431 and (EU) 2025/161. 

(2) The holder of the authorisations for the feed additives concerned, DSM Nutritional Products Ltd., has submitted an application in accordance with Article 13(3) of Regulation (EC) No 1831/2003 proposing to change the name of the holder of the authorisations for the feed additives concerned to Novozymes A/S. 

(3) The proposed change of the terms of the authorisations is purely administrative in nature and does not entail a new assessment of the feed additives concerned. The European Food Safety Authority was informed of the application. 

(4) To allow Novozymes A/S to exploit its marketing rights, it is necessary to change the terms of the authorisations concerned.

(5) Commission Implementing Regulations (EU) 2021/1426, (EU) 2024/221, (EU) 2023/1333, (EU) 2024/1058, (EU) 2023/1342, (EU) 2024/778, (EU) 2024/2177, (EU) 2019/805, (EU) 2020/163, (EU) 2021/1431 and (EU) 2025/161 should therefore be amended accordingly. 

(6) Since safety reasons do not require the immediate application of the amendments made by this Regulation, it is appropriate to allow a transitional period during which existing stocks of the feed additives concerned may be used up. 

(7) The measures provided for in this Implementing Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,